Close Menu

PCR arrays

LGC said that the acquisition will increase its presence in the nucleic acid market, in addition to its previous acquisitions in the last few years.

The firm sees the new panel as an important step forward in its strategy to further penetrate the molecular diagnostics market with its qPCR products.

In counting defective proviruses, approaches for estimating the size of HIV patients' virus reservoirs are throwing off estimates of treatment effectiveness.

LGC said it plans to use Douglas Scientific's PCR and qPCR platforms to provide customers with enhanced high-throughput genotyping and qPCR instruments.

Available in March, the PCR-based FilmArray 2.0 platform has higher throughput and takes up a smaller footprint.

NEW YORK (GenomeWeb News) – A study online today in the Journal of Clinical Investigation suggests cigarette smoke may exert some of its negative, cancer-promoting effects through an epigenetic pathway that curtails the activity of a microRNA called miR-487b.

Akonni Biosystems and Albany, NY-based Wadsworth Center are working together under a $300,000 National Institutes of Health grant to develop a closed amplicon PCR microarray to detect encephalitis- and meningitis-causing viruses in cerebral spinal fluid, Akonni said this week.

The companies have partnered to offer more than 100 pathway-focused gene expression panels validated for real-time PCR analysis on Fluidigm's BioMark system.

While Qiagen is primarily interested in SABiosciences' PCR Arrays and bioinformatics tools, the company also offers a number of microarray resources, including its own line of focused gene-expression arrays, a menu of reagent kits, data-analysis software, and core services on the Agilent Technologies and Illumina platforms.

Qiagen’s goal is to enable its customers to take an assay in a very early stage of discovery and validation and, “without transitioning platforms — to seamlessly move that into a companion diagnostic candidate if they so wish."

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.